ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 26 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,000 | – | 5,936 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eventide Asset Management | 590,602 | $1,577,000 | 0.02% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,020,748 | $2,725,000 | 0.02% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,058 | $62,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 110,000 | $294,000 | 0.01% |
| Alberta Investment Management Corp | 130,000 | $347,000 | 0.00% |
| Jaffetilchin Investment Partners, LLC | 11,000 | $29,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 164,229 | $438,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 162,942 | $435,000 | 0.00% |
| Janney Montgomery Scott LLC | 69,487 | $186,000 | 0.00% |
| Renaissance Technologies | 391,629 | $1,046,000 | 0.00% |